Clinical Trial Update: NeoVas Bioresorbable Coronary Scaffold Registry Study [NA]

View source ↗

Summary

Registry update for the NeoVas Bioresorbable Coronary Scaffold Registry sponsored by Lepu Medical Technology (Beijing). The current status of the study is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• NeoVas Bioresorbable Coronary Scaffold

Snippet

Sponsor: Lepu Medical Technology (Beijing) Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN